[ SOURCE: Reuters] As of June 2, 2025, the JPML reports there are 1,882 cases pending in the MDL -3094 IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
Anyone with cancer concerns should discuss Wnt-modulating treatments with an oncologist before use
Our current MSM products: Our MSM features high-purity OptiMSM , produced through an innovative 4-phase distillation process ensuring maximum purity, bioavailability, and tolerability
Direct answer: Official semaglutide prescribing information says pregnancy is a reason for caution or discontinuation
GLP-1 additionally exerts various effects outside the pancreas, including regulation of food intake and appetite (12), inhibition of gastrointestinal motility and secretion (13) and a cardioprotective effect (14,15)